Peter Bart Reiner
Kinsmen Laboratory of Neurological Research
University of British Columbia
Graduate Group: Anatomy
Thesis Topic: The activity of neurons in the area of the Locus Coeruleus during the states of sleep
Dr. Reiner has studied the neurobiology of behavioral states and the molecular underpinnings of neurodegenerative disease. He also has experience in the private sector as President and CEO of Active Pass Pharmaceuticals, a drug discovery company that he founded to tackle the Alzheimer's disease. Currently Dr. Reiner's work focuses in the area of neuroethics, with interests in neuroessentialism, the neuroethics of cognitive enhancement, and the commercialization of neuroscience.